-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Revolution Medicines, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q2 2024.
- Revolution Medicines, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $19.8M, a 52.4% increase year-over-year.
- Revolution Medicines, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $75.1M, a 91.8% increase year-over-year.
- Revolution Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $61.8M, a 98% increase from 2022.
- Revolution Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31.2M, a 50.5% increase from 2021.
- Revolution Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $20.7M, a 133% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)